These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11340455)

  • 21. Familial clustering of end-stage renal disease in Mississippi.
    Butkus DE
    J Miss State Med Assoc; 2002 Mar; 43(3):71-7. PubMed ID: 11944578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes for primary glomerulonephritis: New Zealand Glomerulonephritis Study.
    Chembo CL; Marshall MR; Williams LC; Walker RJ; Lynn KL; Irvine J; Pilmore HL
    Nephrology (Carlton); 2015 Dec; 20(12):899-907. PubMed ID: 26096749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family history of end-stage renal disease among hemodialyzed patients in Poland.
    Gumprecht J; Zychma MJ; Moczulski DK; Gosek K; Grzeszczak W
    J Nephrol; 2003; 16(4):511-5. PubMed ID: 14696752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease.
    Iseki K; Kimura Y; Wakugami K; Okumura K; Muratani H; Ikemiya Y; Fukiyama K
    Hypertens Res; 2000 Mar; 23(2):143-9. PubMed ID: 10770261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking.
    Ward MM; Studenski S
    Arch Intern Med; 1992 Oct; 152(10):2082-8. PubMed ID: 1417382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-stage renal disease and acute glomerulonephritis in Goajiro Indians.
    Herrera J; Rodríguez-Iturbe B
    Kidney Int Suppl; 2003 Feb; (83):S22-6. PubMed ID: 12864870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Wetmore JB; Guo H; Liu J; Collins AJ; Gilbertson DT
    Kidney Int; 2016 Oct; 90(4):853-60. PubMed ID: 27425855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glomerulopathies as causes of end-stage renal disease in children].
    Ziółkowska H; Adamczuk D; Leszczyńska B; Roszkowska-Blaim M
    Pol Merkur Lekarski; 2009 Apr; 26(154):301-5. PubMed ID: 19580193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End-Stage Renal Disease and Mortality Outcomes Across Different Glomerulonephropathies in a Large Diverse US Population.
    Sim JJ; Bhandari SK; Batech M; Hever A; Harrison TN; Shu YH; Kujubu DA; Jonelis TY; Kanter MH; Jacobsen SJ
    Mayo Clin Proc; 2018 Feb; 93(2):167-178. PubMed ID: 29395351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical correlates of hypertensive end-stage renal disease.
    Bleyer AJ; Chen R; D'Agostino RB; Appel RG
    Am J Kidney Dis; 1998 Jan; 31(1):28-34. PubMed ID: 9428448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expanding spectrum of renal diseases associated with antiphospholipid syndrome.
    Fakhouri F; Noël LH; Zuber J; Beaufils H; Martinez F; Lebon P; Papo T; Chauveau D; Bletry O; Grünfeld JP; Piette JC; Lesavre P
    Am J Kidney Dis; 2003 Jun; 41(6):1205-11. PubMed ID: 12776272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An improved understanding of the causes of end-stage renal disease.
    Young EW
    Semin Nephrol; 1997 May; 17(3):170-5. PubMed ID: 9165646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study.
    O'Dea DF; Murphy SW; Hefferton D; Parfrey PS
    Am J Kidney Dis; 1998 Nov; 32(5):794-801. PubMed ID: 9820449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.
    Kapitsinou PP; Ioannidis JP; Boletis JN; Sotsiou F; Nakopoulou L; Daphnis E; Moutsopoulos HM
    Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.